mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.05 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.06 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.06 |